Back

Low-dose administration of carperitide for Acute Heart Failure

11 May 2024 (14:33 - 14:41)
Organised by: Logo
Congress Presentation Part of: Late breaking clinical trials: medical therapy Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Associate Professor Toshiyuki Nagai

Hokkaido University, Sapporo (Japan)

9 More presentations in this session

Presentation thumbnail
A phase 2b, randomised, double-blind, active controlled, multi centre study to evaluate the efficacy, safety and tolerability of oral AZD9977 and dapagliflozin treatment in patients with heart failure
Professor C. Lam (Singapore, SG)
Slides Video
Presentation thumbnail
Discussant review - MIRACLE
Professor M. Packer (Dallas, US)
Slides Video
Presentation thumbnail
A phase 2, randomized, double-blind, placebo-controlled study to assess the tolerability and pharmacodynamic effects of CRD-740, a PDE9 inhibitor, in participants with chronic heart failure
Professor J. Udelson (Boston, US)
Slides Video
Presentation thumbnail
Discussant review - CARDINAL HF
Associate Professor A. Bohm (Bratislava, SK)
Slides Video
Presentation thumbnail
Readily available urinary sodium analysis in patients with acute decompensate Heart Failure
Doctor E. Meekers (Genk, BE)
Slides Video

Access the full session

Session thumbnail
Late breaking clinical trials: medical therapy
Video

The Event

Event poster

Heart Failure 2024

11 May 2024 14:33 CET
You may be interested in
thumbnail
Congress Session
Registries and Trial updates II
23 May 2022
thumbnail
Congress Presentation
Early in-hospital initiation of angiotensin-neprilysin inhibition in Japanese patients with acute heart failure: the investigator-initiated multicenter randomized PREMIER study
31 August 2024
thumbnail
Congress Presentation
Effect of short-term prednisone therapy on C-reactive protein change in emergency department patients with acute heart failure and elevated inflammatory markers
30 August 2024
thumbnail
Congress Presentation
Highlights on 'heart failure'
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources